Allurion Technologies (ALURD) Operating Income Growth (1y) (2023 - 2026)
Allurion Technologies (ALURD) Operating Income Growth (1y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | -17.50% |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 49.06% |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 30.43% |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 43.83% |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | 24.81% |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | 49.72% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 13.00% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 57.74% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 16.18% |
| 10 | Allurion Technologies | 49.18 Mn | 44.13 Mn | 1.23 Mn | 48.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 48.76% |
| Dec 31, 2025 | 63.44% |
| Sep 30, 2025 | 21.97% |
| Jun 30, 2025 | 25.62% |
| Mar 31, 2025 | 36.07% |
| Dec 31, 2024 | 33.50% |
| Sep 30, 2024 | 52.81% |
| Jun 30, 2024 | 29.70% |
| Mar 31, 2024 | 18.06% |
| Dec 31, 2023 | -153.63% |
| Sep 30, 2023 | -118.22% |
| Jun 30, 2023 | -209.67% |